DA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Oct 2024)
What this means for you
Registered since 12 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86939709
- Registration number
- 5492665
- Mark type
- Stylized text
- Filed
- 14 Mar 2016
- Published for opposition
- 02 Aug 2016
- Registered
- 12 Jun 2018
- Attorney of record
- Scott S. Havlick
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient
Owner
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP
Prosecution history
- 31 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 May 2024 — TEAS SECTION 8 & 15 RECEIVED
- 12 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Mar 2018 — USE AMENDMENT FILED
- 16 Apr 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Mar 2018 — TEAS STATEMENT OF USE RECEIVED
- 28 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2018 — SOU EXTENSION 3 GRANTED
- 26 Mar 2018 — SOU EXTENSION 3 FILED